Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bryn Nelson

Showing results (161-170 of 186) with videos related to

Pageof 19
Sort By:
Cancer Cytopathology|February 2, 2023
Generalists and specialists: Two sides of the same coin for cancer care?: Amid growing concern over a decline in generalists, experts are urging new incentives to extend their reach and are paying more attention to key generalist tools that even specialists can tap: Amid growing concern over a decline in generalists, experts are urging new incentives to extend their reach and are paying more attention to key generalist tools that even specialists can tapBryn Nelson, William Faquin
Cancer Cytopathology|March 4, 2026
A growing brain drain: US policies are spurring medical researchers to pursue other options: In this third of a three-part series on how new US policies and funding cuts are affecting cancer research, scientists are increasingly looking abroad for better offers and more stabilityBryn Nelson, William Faquin
Cancer Cytopathology|June 2, 2026
Cysteine-mapping efforts offer new tools for drug development and discovery: Research groups are characterizing cysteine binding and reactivity traits to provide important new starting points for drug designBryn Nelson, William Faquin
Cancer Cytopathology|October 1, 2021
Tracking the twists and turns of a tumor's evolution: Concepts more familiar to evolutionary biologists and ecologists are aiding the scientific quest to understand how tumors evolve and might be steered toward new vulnerabilitiesBryn Nelson, David B Kaminsky
Cancer Cytopathology|January 4, 2021
A growing drive to get rid of cancer-linked "forever chemicals": As concern mounts over the health effects of a huge and ubiquitous family of persistent organic compounds, researchers are making headway on remediation strategies despite uncertainties over costs and regulationsBryn Nelson, David B Kaminsky
Cancer Cytopathology|September 5, 2020
COVID-19's crushing mental health toll on health care workers: Beyond its devastating physical effects, the pandemic has unleashed a mental health crisis marked by anxiety, depression, posttraumatic stress disorder, and even suicide. Here, in part 1 of a 2-part series, we examine the growing effort to identify and alleviate the fallout for health care workersBryn Nelson, David B Kaminsky
Cancer Cytopathology|November 1, 2021
Diversity, equity, and inclusion in pathology: Some progress, but room for improvement: Amid a troubling backslide in diversifying medicine, pathologists point to recent successes and remaining challenges in promoting diversity, equity, and inclusion (DEI). In part 1 of a 2-part series, we investigate what has and has not worked in efforts to diversify workforcesBryn Nelson, David B Kaminsky
Cancer Cytopathology|June 2, 2020
Shining a new light on radiation's dark dide: Cold War era archives and chemical tinkering are helping researchers to better understand how radiation kills and how to protect against it. In this article, the first of a 2-part series, we examine the complicated interplay between radiation and cancerBryn Nelson, David B Kaminsky
Cancer Cytopathology|September 3, 2021
Piecing together a fuller picture of marijuana's potential harms: Marijuana has been both lauded and lambasted for its potential effects on the body. Here, in part 2 of a 2-part series, we investigate the accumulating evidence for acute and long-term harms, particularly during adolescenceBryn Nelson, David B Kaminsky
Cancer Cytopathology|March 5, 2021
Bending the virtual conference learning curve: After COVID-19 forced cytopathology conferences and meetings online, organizers have adapted and found some unexpected benefits amid the downsidesBryn Nelson, David B Kaminsky
Pageof 19

Showing results (161-170 of 186) with videos related to

Sort By:
Pageof 19
Cancer Cytopathology|February 2, 2023
Generalists and specialists: Two sides of the same coin for cancer care?: Amid growing concern over a decline in generalists, experts are urging new incentives to extend their reach and are paying more attention to key generalist tools that even specialists can tap: Amid growing concern over a decline in generalists, experts are urging new incentives to extend their reach and are paying more attention to key generalist tools that even specialists can tapBryn Nelson, William Faquin
Cancer Cytopathology|March 4, 2026
A growing brain drain: US policies are spurring medical researchers to pursue other options: In this third of a three-part series on how new US policies and funding cuts are affecting cancer research, scientists are increasingly looking abroad for better offers and more stabilityBryn Nelson, William Faquin
Cancer Cytopathology|June 2, 2026
Cysteine-mapping efforts offer new tools for drug development and discovery: Research groups are characterizing cysteine binding and reactivity traits to provide important new starting points for drug designBryn Nelson, William Faquin
Cancer Cytopathology|October 1, 2021
Tracking the twists and turns of a tumor's evolution: Concepts more familiar to evolutionary biologists and ecologists are aiding the scientific quest to understand how tumors evolve and might be steered toward new vulnerabilitiesBryn Nelson, David B Kaminsky
Cancer Cytopathology|January 4, 2021
A growing drive to get rid of cancer-linked "forever chemicals": As concern mounts over the health effects of a huge and ubiquitous family of persistent organic compounds, researchers are making headway on remediation strategies despite uncertainties over costs and regulationsBryn Nelson, David B Kaminsky
Cancer Cytopathology|September 5, 2020
COVID-19's crushing mental health toll on health care workers: Beyond its devastating physical effects, the pandemic has unleashed a mental health crisis marked by anxiety, depression, posttraumatic stress disorder, and even suicide. Here, in part 1 of a 2-part series, we examine the growing effort to identify and alleviate the fallout for health care workersBryn Nelson, David B Kaminsky
Cancer Cytopathology|November 1, 2021
Diversity, equity, and inclusion in pathology: Some progress, but room for improvement: Amid a troubling backslide in diversifying medicine, pathologists point to recent successes and remaining challenges in promoting diversity, equity, and inclusion (DEI). In part 1 of a 2-part series, we investigate what has and has not worked in efforts to diversify workforcesBryn Nelson, David B Kaminsky
Cancer Cytopathology|June 2, 2020
Shining a new light on radiation's dark dide: Cold War era archives and chemical tinkering are helping researchers to better understand how radiation kills and how to protect against it. In this article, the first of a 2-part series, we examine the complicated interplay between radiation and cancerBryn Nelson, David B Kaminsky
Cancer Cytopathology|September 3, 2021
Piecing together a fuller picture of marijuana's potential harms: Marijuana has been both lauded and lambasted for its potential effects on the body. Here, in part 2 of a 2-part series, we investigate the accumulating evidence for acute and long-term harms, particularly during adolescenceBryn Nelson, David B Kaminsky
Cancer Cytopathology|March 5, 2021
Bending the virtual conference learning curve: After COVID-19 forced cytopathology conferences and meetings online, organizers have adapted and found some unexpected benefits amid the downsidesBryn Nelson, David B Kaminsky
Pageof 19